Madrigal Pharmaceuticals
Trade Madrigal Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MDGL
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia.
MDGL Key Statistics
Stock Snapshot
As of today, Madrigal Pharmaceuticals(MDGL) shares are valued at $497.27. The company's market cap stands at 11.45B, with a P/E ratio of -38.85.
As of 2026-05-31, Madrigal Pharmaceuticals(MDGL) stock has fluctuated between $496.63 and $520.31. The current price stands at $497.27, placing the stock +0.1% above today's low and -4.4% off the high.
Madrigal Pharmaceuticals(MDGL) shares are trading with a volume of 435.16K, against a daily average of 268.79K.
In the last year, Madrigal Pharmaceuticals(MDGL) shares hit a 52-week high of $615.00 and a 52-week low of $265.20.
In the last year, Madrigal Pharmaceuticals(MDGL) shares hit a 52-week high of $615.00 and a 52-week low of $265.20.
MDGL News
...
Madrigal Pharmaceuticals recently announced that multiple new data sets from its Rezdiffra development and real‑world evidence programs were presented at the EA...
Analyst ratings
89%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.